Early Detection.
Better Brain Support.
Bio Aurum develops innovative products at the intersection of medical technology, neuroscience and nutraceutical research. Our mission is to create solutions that can improve the way neurodegenerative conditions are assessed, understood and supported.
For this reason, Bio Aurum develops two complementary products: Neuretina MD, a medical device for eye-movement analysis, and a saffron-based nutraceutical designed to support brain health through a neuroprotective approach.
Two Complementary Products, One Focused Mission
Neuretina MD
Saffron-Based Nutraceuticals
Our approach combines neuroscience, translational science and clinical relevance with proprietary technology, rigorous development standards and stringent validation to advance brain health.
A Critical Need for Change
According to the WHO*:
- 57 million patients suffer from various forms of dementia.
- Alzheimer's Disease (AD) is the most common form (approximately 60-70% of dementia cases worldwide), followed by Parkinson's Disease (PD).
While the underlying pathology of AD and PD are different, they share two key factors:
Aging and neuroinflammation play an active role in the pathogenesis of both.
Currently, there are no disease-modifying or curative therapies. Existing treatments provide only symptomatic relief.
While no cure currently exists, early diagnosis remains crucial, as it enables early treatments that may help manage symptoms and support overall function.
Neuretina MD
An assessment device based on eye-tracking for the early detection of neurodegenerative diseases.
